Who is sponsoring NCT04142164?

NCT04142164 is sponsored by Prim. Prof. Dr. Oliver Findl, MBA.

What drugs are being tested in NCT04142164?

Interventions in NCT04142164: MacInfo presentation, Placebo presentation.

What condition does NCT04142164 study?

NCT04142164 studies Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema.

Is NCT04142164 still recruiting?

NCT04142164 is currently status unknown. Last updated 8 February 2022.

Last reviewed 2022-02-08 · How we verify

NCT04142164

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections

Status unknown NA Last updated 8 February 2022

What this trial tests

NA trial testing MacInfo presentation in Age-related Macular Degeneration in 40 participants. Status unknown.

Timeline

24 October 2019

Primary endpoint
1 January 2023

1 January 2024

Quick facts

Lead sponsor	Prim. Prof. Dr. Oliver Findl, MBA
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	40
Start date	24 October 2019
Primary completion	1 January 2023
Estimated completion	1 January 2024
Sites	1 location across Austria

Drugs / interventions tested

MacInfo presentation
Placebo presentation

Conditions studied

Age-related Macular Degeneration — all drugs for Age-related Macular Degeneration →
Retinal Vein Occlusion — all drugs for Retinal Vein Occlusion →
Diabetic Macular Edema — all drugs for Diabetic Macular Edema →

Sponsor

Prim. Prof. Dr. Oliver Findl, MBA

Who can join

Adults 21 to 105, any sex, with Age-related Macular Degeneration or Retinal Vein Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation if a computer-based tutorial ("MacInfo" tool) improves the patients' knowledge about intravitreal drug injections, associated risks, and the underlying diseases of treatment-naive patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Human retinal secretome: A cross-link between mesenchymal and retinal cells.
Donato L, Scimone C, Alibrandi S, Scalinci SZ, et al · · 2023 · cited 6× · PMID 37545752 · DOI 10.4252/wjsc.v15.i7.665

Verify or expand the search:

Other recruiting trials for Age-related Macular Degeneration

Currently open trials in the same condition.

NCT06961370 — A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO76693 · Phase 1 · recruiting
NCT06458595 — Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) · Phase 1, PHASE2 · recruiting
NCT03848663 — Visual Remapping to Aid Reading With Field Loss · NA · recruiting
NCT04735263 — Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD · Phase 2 · recruiting
NCT03752840 — Village-Integrated Eye Worker Trial II · NA · recruiting

Other Prim. Prof. Dr. Oliver Findl, MBA trials

Trials by the same sponsor.

NCT07425626 — Brillouin Scanning in Cataractous Eyes · active not recruiting
NCT06624826 — Visual Performance of an Extended Depth of Focus IOL in an Emmetropic or Monovision Modality · NA · recruiting
NCT06459284 — Instrument Tissue Interaction at the Grasp Site During Membrane Peeling of Epiretinal Membranes · completed
NCT06948851 — New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes · active not recruiting
NCT07436247 — Pseudophakic Eyes With Presbyopia-correcting IOLs: OCT Biometry and Pyramid Aberrometry · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04142164 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prim. Prof. Dr. Oliver Findl, MBA
Last refreshed: 8 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04142164.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing